Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 41.97%665.15M | 65.76%926.97M | 276.56%468.51M | 262.58%559.21M | 58.76%124.42M | -62.21%154.23M | -61.60%78.37M | 45.95%408.12M | 69.66%295.28M | --204.08M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 66.62%-1.65M | 34.56%-6.13M | 31.35%-4.95M | -1,050.49%-9.37M | -2,343.73%-7.21M | -76.96%-814K | -24.47%-295K | 78.35%-460K | 57.38%-335K | ---237K |
| Attributable subsidiary (profit) loss | -126.57%-797K | -73.14%1.61M | 4.06%3M | 388.61%6.01M | 648.83%2.88M | 724.83%1.23M | 187.90%385K | 108.00%149K | 77.61%-165K | ---438K |
| Impairment and provisions: | -24.16%18.12M | 299.00%45.71M | 812.61%23.89M | -74.88%11.46M | -88.22%2.62M | -37.67%45.6M | -54.94%22.22M | 165.61%73.16M | 15.39%32.05M | --49.31M |
| -Impairmen of inventory (reversal) | -21.06%14.93M | 45.05%38.74M | 8.91%18.91M | -20.38%26.71M | -19.17%17.36M | -49.83%33.55M | -53.67%21.48M | 101.46%66.86M | -12.60%27.56M | --46.36M |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | -2,094.86%-14.74M | 91.24%12.05M | -74.96%739K | 211.70%6.3M | 219.95%4.5M | --2.95M |
| -Other impairments and provisions | -35.94%3.19M | 145.69%6.97M | --4.99M | ---15.25M | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | -136.70%-3.7M | -19.73%-19.3M | 161.42%10.09M | -20,306.33%-16.12M | -24,786.36%-16.43M | 51.23%-79K | ---66K | ---162K | ---71K | ---- |
| -Other fair value changes | -136.70%-3.7M | -19.73%-19.3M | 161.42%10.09M | -20,306.33%-16.12M | -24,786.36%-16.43M | 51.23%-79K | ---66K | ---162K | ---71K | ---- |
| Asset sale loss (gain): | -248.47%-23.06M | 3,193.33%1.98M | -11,126.67%-6.62M | -92.67%60K | -87.68%60K | 161.09%818K | 174.12%487K | 31.54%-1.34M | -22.03%-1.82M | ---657K |
| -Loss (gain) from sale of subsidiary company | ---- | --2.6M | ---- | ---- | ---- | ---- | ---- | -46.33%351K | ---1.09M | ---660K |
| -Loss (gain) on sale of property, machinery and equipment | 301.23%1.15M | -366.67%-160K | -1,050.00%-570K | 36.36%60K | -87.70%60K | 102.67%44K | 687.10%488K | -79.85%-1.65M | -542.86%-899K | --62K |
| -Loss (gain) from selling other assets | -300.30%-24.2M | ---464K | ---6.05M | ---- | ---- | 2,084.62%774K | 98.31%-1K | 97.70%-39K | 110.17%172K | ---59K |
| Depreciation and amortization: | 20.04%64.68M | 5.32%105.95M | 10.93%53.88M | 6.83%100.6M | -1.94%48.58M | 6.90%94.17M | 25.91%49.54M | 5.10%88.1M | 4.07%66.09M | --39.35M |
| -Amortization of intangible assets | -1.45%1.36M | 1.35%2.77M | 1.92%1.38M | -25.40%2.74M | -8.69%1.36M | 64.75%3.67M | -7.13%1.48M | -19.49%2.23M | 0.68%1.77M | --1.6M |
| Financial expense | -11.28%2.8M | -62.58%6.07M | -72.93%3.16M | -20.74%16.23M | 19.05%11.66M | -2.20%20.47M | -25.54%9.79M | -48.31%20.93M | -45.25%16.62M | --13.15M |
| Special items | -38.39%3.58M | 31.64%6.55M | 46.49%5.82M | 661.51%4.98M | 70.65%3.97M | -102.14%-886K | -92.53%2.33M | -21.87%41.44M | -29.49%36.3M | --31.14M |
| Operating profit before the change of operating capital | 30.24%725.13M | 58.89%1.07B | 226.46%556.78M | 113.84%673.05M | 4.79%170.55M | -50.04%314.75M | -51.52%162.76M | 31.62%629.95M | 29.00%443.96M | --335.7M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 95.18%-6.99M | -1,029.71%-218.62M | -611.81%-144.83M | -127.83%-19.35M | 0.11%28.3M | 162.78%69.54M | 136.05%28.27M | -6.26%-110.77M | 53.59%-61.37M | ---78.41M |
| Accounts receivable (increase)decrease | 2,161.38%48.36M | -257.75%-111.11M | -102.37%-2.35M | 675.28%70.44M | 23.70%98.81M | 68.56%-12.24M | 410.95%79.88M | -275.20%-38.95M | -102.08%-2.22M | ---25.69M |
| Accounts payable increase (decrease) | -105.72%-7.33M | 78.87%258.68M | 268.45%128.16M | 148.08%144.62M | 74.54%-76.08M | -327.95%-300.77M | -2,552.02%-298.78M | 41.87%-70.28M | -28.59%-107.59M | --12.19M |
| prepayments (increase)decrease | -7.90%-265.21M | -133.27%-322.67M | -268.62%-245.78M | -4,009.39%-138.32M | -2,718.13%-66.68M | 94.71%-3.37M | 95.93%-2.37M | -124.87%-63.67M | -180.42%-81.73M | ---58.16M |
| Special items for working capital changes | ---- | ---- | ---- | 200.00%11.5M | 200.00%11.5M | -2,713.64%-11.5M | -895.67%-11.5M | -98.68%440K | -104.43%-1.21M | ---1.16M |
| Adjustment items for working capital changes | ---- | ---- | ---1K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from business operations | 69.17%493.96M | -8.93%675.68M | 75.47%291.99M | 1,215.25%741.93M | 498.67%166.4M | -83.73%56.41M | -122.63%-41.74M | 23.58%346.72M | -18.63%189.84M | --184.47M |
| Other taxs | -38.06%-109.97M | -2,526.23%-134.86M | -3,945.40%-79.65M | 75.15%-5.14M | 94.05%-1.97M | -72.41%-20.66M | -211.74%-33.11M | 28.29%-11.99M | 29.46%-11M | ---10.62M |
| Interest received - operating | -66.62%1.65M | -34.56%6.13M | -31.35%4.95M | 1,050.49%9.37M | 2,343.73%7.21M | 76.96%814K | 24.47%295K | -78.35%460K | -57.38%335K | --237K |
| Net cash from operations | 77.48%385.63M | -26.70%546.95M | 26.59%217.28M | 1,940.87%746.16M | 330.21%171.64M | -89.09%36.56M | -142.83%-74.56M | 26.02%335.19M | -18.00%179.17M | --174.08M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | --688K | ---- | ---- | ---- | ---- | ---- | ---- | --2.1M | --1.84M | --1.84M |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.48%490K | 100.68%490K | --490K |
| Sale of fixed assets | -88.34%216K | 146.27%8.79M | -42.98%1.85M | -26.22%3.57M | 546.12%3.25M | 0.75%4.84M | 38.95%503K | 415.57%4.8M | -42.49%429K | --362K |
| Purchase of fixed assets | -7.36%-129.5M | -165.69%-233.37M | -242.02%-120.62M | -61.67%-87.83M | -11.56%-35.27M | 13.93%-54.33M | 23.10%-31.61M | 54.85%-63.12M | 55.83%-47.06M | ---41.11M |
| Selling intangible assets | ---- | 169.37%1.16M | 180.79%848K | -21.49%431K | --302K | -74.84%549K | ---- | 12.13%2.18M | 516.77%1.03M | ---- |
| Purchase of intangible assets | -146.46%-1.22M | -1,338.59%-9.21M | -49.55%-495K | 88.85%-640K | 85.64%-331K | -120.21%-5.74M | 10.59%-2.31M | -62.53%-2.61M | -6,325.00%-3.08M | ---2.58M |
| Sale of subsidiaries | ---- | 1,673.04%8.16M | ---- | --460K | ---- | ---- | ---- | -79.09%700K | -82.49%300K | --300K |
| Recovery of cash from investments | 43.15%326.58M | --389.77M | --228.14M | ---- | ---- | 99.09%58.08M | --8.07M | -7.21%29.17M | -67.95%10.08M | ---- |
| Cash on investment | 10.72%-214.04M | 5.66%-352.33M | 24.91%-239.74M | -432.17%-373.47M | -762.89%-319.27M | -142.00%-70.18M | -270.00%-37M | -974.87%-29M | -6,566.67%-20M | ---10M |
| Net cash from investment operations | 86.71%-17.28M | 59.12%-187.03M | 62.99%-130.01M | -585.02%-457.49M | -463.47%-351.32M | -20.80%-66.78M | -23.00%-62.35M | -696.05%-55.29M | 61.32%-55.98M | ---50.69M |
| Net cash before financing | 322.09%368.36M | 24.68%359.92M | 148.57%87.27M | 1,055.16%288.68M | -31.24%-179.68M | -110.80%-30.22M | -210.95%-136.91M | 8.06%279.91M | 66.95%123.2M | --123.39M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 238.12%238.65M | -37.89%220M | -75.38%70.58M | -42.46%354.22M | 32.85%286.72M | 1,427.54%615.6M | 2,058.20%215.82M | -91.48%40.3M | -96.40%10M | --10M |
| Refund | 74.05%-28.7M | 71.27%-259.93M | 83.68%-110.59M | -482.51%-904.58M | -1,406.90%-677.65M | 45.60%-155.29M | 70.08%-44.97M | 55.84%-285.45M | 61.21%-150.31M | ---150.32M |
| Issuing shares | ---- | ---- | ---- | -97.43%21.78M | --21.78M | --846.41M | ---- | ---- | ---- | ---- |
| Interest paid - financing | 11.28%-2.8M | 62.58%-6.07M | 72.93%-3.16M | 20.74%-16.23M | -19.05%-11.66M | -38.67%-20.47M | 25.54%-9.79M | 66.09%-14.77M | 35.02%-16.67M | ---13.15M |
| Dividends paid - financing | -158.65%-368.87M | -191.51%-522.04M | ---142.62M | 10.46%-179.08M | ---- | ---200M | ---50.18M | ---- | ---- | ---- |
| Absorb investment income | 745.45%9.3M | -1.76%18.45M | -89.80%1.1M | 138.93%18.78M | 37.15%10.78M | --7.86M | --7.86M | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | 88.97%-4.19M | ---3.19M | ---37.96M | ---- | ---- | ---- | ---- |
| Other items of the financing business | 119.34%1.55M | -2,766.67%-8M | -2,766.67%-8M | 122.46%300K | --300K | -2.85%-1.34M | ---- | ---1.3M | ---- | ---- |
| Net cash from financing operations | 18.74%-171.67M | 19.20%-595.67M | 45.22%-211.24M | -171.71%-737.21M | -462.08%-385.59M | 455.05%1.03B | 164.99%106.49M | -20.68%-289.56M | -8.32%-172.76M | ---163.86M |
| Effect of rate | 210.19%4.77M | -67.05%-2.48M | -202.30%-4.33M | -131.90%-1.49M | -927.75%-1.43M | 605.30%4.66M | 169.48%173K | -75.73%661K | -22.10%1.09M | ---249K |
| Net Cash | 258.65%196.69M | 47.44%-235.76M | 78.07%-123.97M | -144.95%-448.53M | -1,758.44%-565.26M | 10,442.43%997.84M | 24.83%-30.42M | -150.52%-9.65M | 42.16%-49.57M | ---40.47M |
| Begining period cash | -34.15%459.45M | -39.21%697.69M | -39.21%697.69M | 690.39%1.15B | 690.39%1.15B | -5.83%145.21M | -5.83%145.21M | 16.48%154.2M | 16.48%154.2M | --154.2M |
| Cash at the end | 16.07%660.91M | -34.15%459.45M | -2.00%569.39M | -39.21%697.69M | 405.38%581.01M | 690.39%1.15B | 1.31%114.97M | -5.83%145.21M | 119.90%105.72M | --113.48M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | Ernst & Young | -- | Ernst & Young Accounting Firm | -- | Ernst & Young Accounting Firm | -- | Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.